6.5 C
New York
Sunday, May 29, 2022

Annual vaccine? US discusses the future of Covid booster doses

Must Read

They Find A Farm Abandoned Hastily 2,100 Years Ago

Farmstead remnants uncovered in Israel date back 2,100 years, suggesting that the proprietors fled the area to...

New Data Suggests Three Foods That Can Protect Our Brain From Dementia

You already know that fruits and vegetables are good for your health. New research suggests some may...

Antidepressants May Not Be The Best Way To Cut Depression, This One Is – Says New Study

Are you looking for an all-natural solution to improve your mood, and memory, and protect your brain...
Jiya Saini
Jiya Saini is a Journalist and Writer at Revyuh.com. She has been working with us since January 2018. After studying at Jamia Millia University, she is fascinated by smart lifestyle and smart living. She covers technology, games, sports and smart living, as well as good experience in press relations. She is also a freelance trainer for macOS and iOS, and In the past, she has worked with various online news magazines in India and Singapore. Email: jiya (at) revyuh (dot) com

On Wednesday, US health experts will meet to discuss the future of the COVID-19 immunization campaign. Members of the Food and Drug Administration (FDA) will decide at the conference whether the fourth dose of the vaccine should be valid for all North Americans and whether the vaccination will be administered annually, as it is with the flu vaccine (influenza).

It’s worth noting that the FDA approved the fourth dosage of the covid-19 vaccination for all adults aged 50 and up, regardless of comorbidity, just last week.

Future of the vaccination strategy

The FDA’s Vaccines and Related Biological Products Advisory Committee will address whether Covid-19 vaccine booster doses will be required in the future, as well as the process for selecting variant-specific boosters and whether the Covid-19 vaccine will become an annual shot.

The FDA vaccine advisory conference is meant to assist build a “general framework” that will help determine when Covid-19 booster doses are needed and when vaccine formulations should be updated to target specific coronavirus strains, according to the FDA.

“As we prepare for future needs to address COVID-19, prevention in the form of vaccines remains our best defense against the disease and any potentially severe consequences,” says Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.

“Now is the time to discuss the need for future boosters as we aim to move forward safely, with COVID-19 becoming a virus like others such as influenza that we prepare for, protect against, and treat,” Marks adds.

“Bringing together our panel of expert scientific external advisors in an open, transparent discussion about booster vaccination is an important step to gain insight, input and expert advice as we begin to formulate the best regulatory strategy to address COVID-19 and virus variants going forward.”

Will the reinforcement of covid be annual, like the flu?

To further comprehend the impending immunization efforts against Covid-19, consider how governments deal with the flu: by administering vaccinations on a year-round basis. Dr. Anthony Fauci, the chief medical adviser to President Joe Biden, suggests this method.

“We don’t know this as a fact, but it could be that we may need an intermittent boost on a yearly basis until we get this level so low down,” explains Fauci during an interview with CNN.

To achieve this goal, it is possible that a new vaccine will be needed every year, “in the same way that we adjust flu shots”, he points out.

Image Credit: Getty

You were reading: Annual vaccine? US discusses the future of Covid booster doses

- Advertisement -
- Advertisement -

Latest News

- Advertisement -

More Articles Like This

- Advertisement -